Cytometry Part B-Clinical Cytometry

Papers
(The median citation count of Cytometry Part B-Clinical Cytometry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
CD34 and CD117 negative pure erythroid leukemia and phenotypic differences with acute megakaryoblastic leukemia30
BCR::ABL1 fusion gene positive de novo acute myeloid leukemia with coexistence of NRAS mutation and presented with a peculiar CD58 positive immunophenotype27
CD62‐L down‐regulation after L18‐MDP stimulation as a complementary flow cytometry functional assay for the diagnosis of XIAP deficiency24
21
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia20
Partial recapitulation of fetal thymic T‐cell constitution postnatally in a patient with cartilage hair hypoplasia‐anauxetic dysplasia spectrum disorder: A case report15
Issue Information15
CD69flow cytometry to complement interferon‐γrelease assay for active tuberculosis15
CLL/SLL specifically binding to the APC fluorochrome: A previously undescribed phenomenon15
Flow cytometry in the diagnosis of myelodysplastic syndromes13
Issue highlights—January 202510
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells10
The use of erythrocytes as biomarkers with a timeline9
An unusual case of cytoplasmic CD3 expressing BPDCN supporting the T‐lineage origin of plasmacytoid dendritic cells9
Issue Information9
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation9
Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma9
9
Issue Highlights—July 20218
8
Acquired RUNX1::CBFA2T2 fusion at extramedullary relapse in a patient of PDGFRA rearranged acute myeloid leukemia post allogenic HSCT7
Issue highlights—May 20237
Deciphering stage 0 hematogones by flow cytometry in follow‐up bone marrow samples of pediatric B—Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy7
7
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring7
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms7
Issue Information7
Detection of CAR‐T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories7
Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact6
Automation in flow cytometry: Guidelines and review of systems6
Issue highlights—November 20236
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder6
Issue Information6
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease6
Focus on the Holdrinet index: Toward blast quantification by flow cytometry5
Immunophenotypic assessment ofPNHclones in major and minor cell lineages in the peripheral blood of patients with paroxysmal nocturnal hemoglobinuria5
5
Correction to “Flow cytometry to detect bone marrow involvement by follicular lymphoma”5
TRBC1 in flow cytometry: Assay development, validation, and reporting considerations5
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry5
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di5
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry5
MAGIC‐DR: An interpretable machine‐learning guided approach for acute myeloid leukemia measurable residual disease analysis5
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor 5
5
An alternative processing approach to increase CD138 intensity in flow cytometric analysis of plasma cells4
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience4
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds4
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients4
cyTRBC1 evaluation rapidly identifies sCD3‐negative peripheral T‐cell lymphomas and reveals a novel type of sCD3‐negative T‐cell clone with uncertain significance4
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience4
4
3
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies3
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes3
Issue Information3
Flow cytometry to detect bone marrow involvement by follicular lymphoma3
Issue highlights—November 20223
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring3
3
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti3
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry3
3
Issue Highlights—May 20223
Standardization of flow cytometric detection of antigen expression3
Issue highlights—September 20233
Issue Information3
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors3
Editorial on IVD cellular assay validation2
Issue Information2
2
Possible alternative strategies to implement basophil activation testing in multicentric studies2
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet2
Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS2
ESCCA/ISCCA survey on the use of multicolor flow cytometry in the detection of cerebrospinal fluid involvement in hematological malignancies: How close does real‐life adhere to t2
2
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening2
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis2
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa2
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data2
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel2
2
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia2
Issue Information2
Issue Information2
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma2
Comparison of flowcytometry‐based scoring system for the diagnosis of early T precursor‐acute lymphoblastic leukemia2
Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex2
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy2
Issue Information2
Application of mass cytometry in multiparametric characterization of precancerous cervical lesions2
Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy2
ClearLLab 10C reagents panel can be applied to analyze paucicellular samples by flow cytometry2
Issue Information1
Issue Information1
ROR1 expression in mature B lymphoid neoplasms by flow cytometry1
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric1
An ultra‐rapid screening method for acute leukemias1
Recommendations for using artificial intelligence in clinical flow cytometry1
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall1
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia1
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care1
Issue highlights—September 20241
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain1
1
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia1
Issue Information1
Resolving 31 colors on a standard 3‐laser full spectrum flow cytometer for immune monitoring of human blood samples1
Issue Information1
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes1
Issue Highlights — May 20211
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD71
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection1
Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach1
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow1
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma1
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients1
A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases1
Issue Information1
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy1
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry1
Analysis of human chromosomes by imaging flow cytometry1
Issue Highlights—January 20221
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow1
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup1
Issue Information1
Issue Information1
Issue highlights—February 20241
1
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation1
Plasma cells show decreased CD138 expression when exposed to buffers containing sodium azide1
Routine flow cytometry approach for the evaluation of solid tumor neoplasms and immune cells in minimally invasive samples1
Issue Highlights—July 20221
Issue Information1
Issue Information1
Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma1
CD4+ T‐cell large granular lymphocytic leukemia with STAT3 mutation and neutropenia1
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes1
Issue highlights—April 20241
0.039483070373535